CiVentiChem Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • CiVentiChem's estimated annual revenue is currently $18.5M per year.(i)
  • CiVentiChem's estimated revenue per employee is $201,000

Employee Data

  • CiVentiChem has 92 Employees.(i)
  • CiVentiChem grew their employee count by 6% last year.

CiVentiChem's People

NameTitleEmail/Phone
1
Managing DirectorReveal Email/Phone
2
Research ScientistReveal Email/Phone
3
President and CEOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.8M294%N/AN/A
#2
$3.2M160%N/AN/A
#3
$83.2M4147%N/AN/A
#4
$31M15456%N/AN/A
#5
$66.6M2650%$35MN/A
#6
$10.9M546%N/AN/A
#7
$6.8M34-6%N/AN/A
#8
$165.7M21614%$250.7MN/A
#9
$26.5M132-11%$637.8KN/A
#10
$49.4M2466%N/AN/A
Add Company

What Is CiVentiChem?

CiVentiChem has been providing excellent services to customers since 1994. Founded by scientists from Duke University as Universal Organics, we have succesfully worked with pharmaceutical, agrochemical and biotechnology companies of all sizes. Our modern laboratory is located in Pittsboro, North Carolina, in the vicinity of Research Triangle Park. We have access to this extensive scientific community as well as the highly skilled work force from major universities including Duke, UNC-Chapel Hill and North Carolina State University.

keywords:N/A

N/A

Total Funding

92

Number of Employees

$18.5M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CiVentiChem News

2022-04-17 - Carglumic Acid Market In-Depth Analysis And Business ...

... Strategies Includes Top Players are Manus Aktteva Biopharma LLP., Civentichem LLC., Recoedati S.p.A, and Dipharma Francis S.r.I.

2022-04-06 - Carglumic Acid Market 2022-2028: Analysis On The Basis Of ...

... On The Basis Of Current Industry Demand, Growth Rate, New Trends And Key Players are Manus Aktteva Biopharma LLP., Civentichem LLC.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.4M922%N/A
#2
$22.8M939%N/A
#3
$13.6M948%N/A
#4
$7.5M9645%N/A
#5
$16.7M96-3%N/A